FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndGross profit (Million JPY)YoY (%)
Mar 31, 20253,453-7.31%
Mar 31, 20243,725+14.23%
Mar 31, 20233,261-41.49%
Mar 31, 20225,574+16.55%
Mar 31, 20214,782+18.29%
Mar 31, 20204,043-18.06%
Mar 31, 20194,934-5.61%
Mar 31, 20185,227+20.61%
Mar 31, 20174,334-7.84%
Mar 31, 20164,703+50.17%
Mar 31, 20153,131
AI Chat